FNY Managed Accounts’s Tandem Diabetes Care TNDM Stock Holding History

FNY Managed Accounts’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$44K	Buy	+9,000	New	+$29K	0.05%	90
2017 Q2	–	Sell	-340	Closed	-$4K	–	584
2017 Q1	$4K	Buy	+340	New	+$7.43K	0.01%	657
2016 Q2	–	Sell	-100	Closed	-$8.71K	–	419
2016 Q1	$8.71K	Buy	+100	New	+$8.75K	0.02%	233
2015 Q1	–	Sell	-1,300	Closed	-$165K	–	426
2014 Q4	$165K	Buy	+1,300	New	+$180K	0.19%	64

Other funds holding TNDM

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

FNY Managed Accounts's TNDM Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Tandem Diabetes Care (TNDM) in Q1 2018: 9,000 shares worth $44K. The stake represents 0.05% of the portfolio and ranks #90 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in TNDM as recently as Q1 2017.

FNY Managed Accounts first reported a position in TNDM in Q4 2014 and has held it in 4 quarters since. The position peaked at $165K in Q4 2014. 75 funds tracked by Wall St. Rank hold TNDM as of Q1 2018.

FNY Managed Accounts held 9,000 shares of Tandem Diabetes Care worth $44K as of Q1 2018.
Tandem Diabetes Care was a new FNY Managed Accounts position in Q1 2018.
Tandem Diabetes Care made up 0.05% of FNY Managed Accounts's portfolio in Q1 2018, its #90 holding.
FNY Managed Accounts first reported a position in Tandem Diabetes Care in Q4 2014 and has held it in 4 quarters since.
FNY Managed Accounts's Tandem Diabetes Care position peaked at $165K in Q4 2014.
75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.